Lung cancer, one of the most aggressive forms of cancer, continues to be a leading cause of death worldwide. Although several new therapies have been developed for this disease, it has a poor prognosis in its advanced stages.
Jun 28, 2023
0
1
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.
Jun 26, 2023
0
47
Tumors are not just isolated clumps of abnormal cells, but are associated with more complex system known as the "tumor microenvironment" (TME). Over the past few years, research has revealed that the TME consists of a complex ...
Jun 13, 2023
0
5
CD8+ T cells, a vital component of the immune system that provides immunity against cancer, have been the focal point of anti-cancer therapies. Recent studies have identified two major subpopulations of these cells present ...
Jun 13, 2023
0
2
A new research perspective titled "HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma" has been published in Oncotarget.
May 24, 2023
0
0
Researchers at the University of Michigan Rogel Cancer Center and the School of Dentistry have identified a new metric to articulate the relationship between nerve density and oral cancer. The study, published in Clinical ...
May 16, 2023
0
3
Cachexia is a syndrome characterized by severe loss of weight and muscle mass. It is present in approximately half of all lung cancer patients and is particularly damaging in cases of non-small cell lung cancer. Early detection ...
May 10, 2023
0
9
A new research perspective was published in Oncotarget, titled "Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism."
May 3, 2023
0
2
A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (SCLC) in a preclinical study. The findings cover new ground in our understanding of how CAR T can ...
Apr 25, 2023
0
11
For 30% to 40% of lymphoma patients who receive CAR T therapy, the treatment is a godsend. Typically given to lymphoma patients for whom other treatments have proven ineffective, CAR T therapy involves removing immune cells ...
Apr 25, 2023
0
2
